Price $64.84 |
Market Cap
2.85B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
184.3
|
P/B
7.9
|
P/S
6.66
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
46.0
|
Op. Cash Flow
90.2K
|
FCF
1.6
|
|
Op. Margin
10.50%
|
Net Margin
4.60%
|
ROE
7.10%
|
ROI
1.50%
|
|
ROA
2.70%
|
EPS Growth
-
|
Current Ratio
2.6
|
Debt/Equity
166.10%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.26 | - | - | 28.5M | Strong Buy |
| Nexeon Medsystems Inc (NXNN) | $6.50 | - | - | 15.7M | Strong Buy |
| Aquinox Pharmaceuticals Inc (AQXP) | $2.93 | - | - | 72.7M | Strong Buy |
| Champions Oncology Inc (CSBR) | $13.23 | - | - | 95.9M | Strong Buy |
| Endo International PLC (ENDP) | $16.12 | - | - | 3.74B | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
